At a glance
ClinicalIndex Comparison RecordN/ACompleted· 105 enrolled
Drug / intervention
Preservative-free saline solution eyedrops +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining
In Brief
A clinical study evaluating Preservative-free saline solution eyedrops, Systane® ULTRA lubricant eyedrops, and 1 other intervention for Dry Eye Syndrome. Completed, enrolled 105 participants.
Detailed Summary
The purpose of this study is to compare Systane® ULTRA lubricant eye drops to OPTIVE® lubricating eye drops for ocular surface staining within dry eye subjects and to evaluate the safety of Systane® ULTRA after 3 months of use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 2013
Enrollment StartSep 2013
Primary CompletionJun 2014
TodayJul 2026
First PostedMay 27, 2013
Enrollment StartSep 1, 2013
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.1 years ago
Interventions
Preservative-free saline solution eyedropsother
1 drop in each eye, 4 times a day, for up to two weeks as washout prior to Phase I and Phase II.
Systane® ULTRA lubricant eyedropsother
OPTIVE® lubricating eyedropsother